Uniwersytet Jagiellonski

Uniwersytet Medyczny W Bialymstoku

Krzysztof Szczubialka

Maria Nowakowska

Kamil Kaminski

Krzysztof Pyrc

Dariusz Pawlak

Mateusz Zajac

Dominik Drozd

Ewa Zuba-Surma

Elzbieta Karnas

Katarzyna Kmiotek-Wasylewska

Aleksandra Synowiec

Magdalena Pachota

Andrzej Mogielnicki

Aleksandra Milewska

Magdalena Wytrwal

Justyna Ciejka

Emilia Sokolowska

Bartlomiej Kalaska

Marta Stolarek

Pawel Botwina

Magdalena Obloza

Kamil Kaminskl

Karolina Zazakowny

The subject of the invention is the use of selected polyelectrolytes from the group of synthetic and natural polyelectrolytes for the cryopreservation of human and animal extracellular vesicles. The invention also relates to a method for the cryopreservation of these vesicles, which uses said poly electrolytes.

Use of polyelectrolytes as cryoprotectants and a method of cryopreservation with their use

The present invention relates to a sulfonated polystyrene derivative of formula I for use in the treatment and/or prophylaxis of cat flu, especially infection caused by feline calicivirus or feline herpesvirus, alone or in combination therapy.

Sulfonated polystyrene derivative for use in the treatment and/or prophylaxis of cat flu

The subject of the invention is use of block polymers with a block of poly(3-methacryloylpropyltrimethylammonium chloride) to direct neutralization of heparin, especially unfractionated heparin and low molecular weight heparins in the blood and other body fluids.

Use of a block polymer comprising a block of poly(3-(methacryloylamino)propyltrimethylammonium chloride) (PMAPTAC) for the neutralization of heparin

The subject of the invention is an N-sulfonic polyallylamine derivative (NSPAH) with Formula 1, wherein R is &#x2014;SOor &#x2014;H, and n is an integer from 150 to 15000; an application of the N-sulfonic polyallylamine derivative as a medicine, particularly for prevention and treatment of respiratory tract infections caused by the human metapneumovirus (hMPV), respiratory tract infections caused by the human rhinoviruses (HRV), and infections caused by the influenza A virus; as well as a pharmaceutical composition comprising the N-sulfonic polyallylamine derivative and application thereof.

Anionically modified polyallylamine derivative, use of anionically modified polyallylamine derivative as medicine, particularly for propylaxis and treatment of infections of respiratory tract caused by human metapneumovirus (hMPV), human rhinoviruses (HRV), and infection by influenza virus type A (IAV) and pharmaceutical composition comprising the anionically modified polyallylamine derivative

The subject of the invention is a hybrid photocatalyst which is a layered aluminosilicate, possibly organically modified, containing compounds introduced into the aluminosilicate galleries bearing groups such as porphyrin, rose bengal, anthracene, pyrene, perylene, tetracene, rubrene, naphthalene, phthalocyanines, coumarins, and methylene blue, which are organic chromophores able to absorb visible and/or ultraviolet light and sensitize photochemical reactions. The invention includes also the methods of synthesis and application of the photocatalysts for the photocatalytical degradation of water pollutants.

Hybrid photocatalysts, the method of their synthesis and use

Growing community of inventors

Krzywaczka, Poland

Krzysztof Szczubialka